As fractional Vice President of Marketing and Communications at Filament Health, a biotech start-up that is the world’s top producer of pharmaceutical psilocybin, I lead the organization’s marcomms strategy. 

I oversee all aspects of public relations, brand positioning, and messaging across channels including media materials, digital platforms, employee engagement, and investor communications. Working closely with the executive and R&D teams, I translate complex scientific concepts into narratives tailored to media, investors, healthcare professionals, and the public.

My role also includes strategic support for major corporate milestones such as funding rounds and regulatory announcements.

A key focus of my work with Filament is media relations and executive visibility. Filament has been featured in top-tier outlets including The Wall Street Journal, The Globe and Mail, Bloomberg, CTV, CBC, and Global News. I’ve also secured high-profile speaking opportunities for the leadership team at industry events such as SxSW, MAPS Psychedelic Science, Horizons Northwest, and the PSYCH Symposium.